1-palmitoyl-lysophosphatidic acid has been researched along with Ovarian Neoplasms in 1 studies
*Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, N; Iwamori, M; Izuka, N; Kumamoto, S; Kuwata, S; Murota, K; Ohkubo, K; Tsujiuchi, T; Yamaguchi, N | 1 |
1 other study(ies) available for 1-palmitoyl-lysophosphatidic acid and Ovarian Neoplasms
| Article | Year |
|---|---|
Extracellular lipid metabolism influences the survival of ovarian cancer cells.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Fatty Acids; Female; Gene Expression Regulation, Neoplastic; Humans; Lipid Metabolism; Lysophospholipids; Ovarian Neoplasms; Ovary | 2013 |